Cannabinoid Encyclopedia

Focused research review

Does CBG help with pain?

CBG may have pain-relevant effects. Several animal studies report benefits in specific neuropathic or osteoarthritis models, while another oral-CBG study did not find a benefit in an inflammatory-pain model. Whether CBG relieves pain in people is still unknown.

Updated July 2026 13 research sources Mostly early-stage research

The short answer

What is the bottom line?

CBG may help with some types of pain, but the current direct evidence comes from animal models, not controlled human pain trials. 1 2 3 4

Two mouse studies reported less mechanical hypersensitivity after isolated CBG in cisplatin-induced neuropathy. A CBG-oil study reported improvements in some osteoarthritis-related measures, although not mechanical allodynia. Other findings were negative, including formalin and tail-flick tests and an oral-CBG rat study of inflammatory pain. 1 2 3 4

What this means: This is a real but mixed preclinical signal. It supports the possibility that CBG could have pain-related effects and supports further human research; it does not tell us whether, how much, or for which pain conditions CBG may help people. 1 2 3 4

How to read this answer: This is a real but mixed preclinical signal. It supports the possibility that CBG could have pain-related effects and supports further human research; it does not tell us whether, how much, or for which pain conditions CBG may help people. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about CBG and pain.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Several animal studies found less mechanical hypersensitivity or other pain-related improvements in specific neuropathic or osteoarthritis models. 1

  2. 2

    The findings were not universal: other pain tests and one oral-CBG inflammatory-pain model did not find a benefit. 2

  3. 3

    The approved CBG pain set does not contain a controlled human pain trial of isolated CBG. 3

  4. 4

    Keep isolated CBG, cannabis extracts, pain type, dose, and route separate when comparing studies. 4

Choose your question

What do you want to know about CBG and pain?

The evidence supports a possibility, not a settled answer. Start by separating the positive and negative animal findings from the still-missing human trials.

  1. 01Reader question

    Could CBG help with pain?

    See why the animal findings support a real possibility while the human answer remains unknown.

    Explore the evidence
  2. 02Reader question

    What do animal models show?

    Compare the positive, mixed, and negative preclinical findings.

    Explore the evidence
  3. 03Reader question

    Do cannabis extracts answer the CBG question?

    No. An extract can contain several active compounds and is not the same as isolated CBG.

    Explore the evidence

Research areas

What researchers studied about CBG and pain

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Too limited for a firm answer

Pain-related outcomes

This part of the literature focuses on Pain-related outcomes. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 6

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

2 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

7 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

4 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on CBG and pain is not one kind of study. This source set includes 6 animal studies, 6 narrative or expert reviews, and 1 systematic review or meta-analysis. 3

The recorded populations or models include people or patients (7 sources), animal models (4 sources), and pediatric, adolescent, or developmental context (1 source). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is pain-related outcomes (13 sources). Closely related outcome names can still describe different measurements. 5

The CBG and pain source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

animal study

Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy.

On this page, this source examines CBG and pain-related outcomes. 1

Study type
animal study
Population or model
animal models
Outcome focus
pain-related outcomes
Evidence stage
mechanism-focused research

animal study

Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain.

On this page, this source examines CBG and pain-related outcomes. 2

Study type
animal study
Population or model
animal models
Outcome focus
pain-related outcomes
Evidence stage
preclinical research

animal study

Therapeutic Effects of Non-Euphorigenic Cannabis Extracts in Osteoarthritis.

On this page, this source examines CBG and pain-related outcomes. 3

Study type
animal study
Population or model
people or patients
Outcome focus
pain-related outcomes
Evidence stage
preclinical research

animal study

Orally administered Cannabigerol (CBG) in rats: Cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain.

On this page, this source examines CBG and pain-related outcomes. 4

Study type
animal study
Population or model
animal models
Outcome focus
pain-related outcomes
Evidence stage
preclinical research

narrative or expert review

Applications of Cannabinoids in Neuropathic Pain: An Updated Review.

On this page, this source examines CBG and pain-related outcomes. 5

Study type
narrative or expert review
Outcome focus
pain-related outcomes
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on CBG and pain should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

Does CBG help with pain?

It may. Several animal studies reported pain-related effects in specific models, while other models did not. No controlled human trial has yet established whether isolated CBG relieves pain in people. 7

What CBG pain studies exist?

The direct literature includes positive mouse studies of cisplatin-induced neuropathy, a mixed CBG-oil osteoarthritis study, and negative findings in other animal pain tests. Reviews and mixed-extract research add context but answer different questions. 8

Why does animal pain research not prove a human result?

Animal models can test biological signals under controlled conditions, but they do not capture every part of human pain, product use, dose, safety, or treatment response. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy. animal study; mechanism-focused research PubMed 35899583 DOI 10.1002/ejp.2016
  2. 2
    Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain. animal study; preclinical research PubMed 37895913 DOI 10.3390/ph16101442
  3. 3
    Therapeutic Effects of Non-Euphorigenic Cannabis Extracts in Osteoarthritis. animal study; preclinical research PubMed 35994012 DOI 10.1089/can.2021.0244
  4. 4
    Orally administered Cannabigerol (CBG) in rats: Cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain. animal study; preclinical research PubMed 39322049 DOI 10.1016/j.pbb.2024.173883
  5. 5
    Applications of Cannabinoids in Neuropathic Pain: An Updated Review. narrative or expert review; evidence still limited PubMed 37824417 DOI 10.1615/critrevtherdrugcarriersyst.2022038592
  6. 6
    Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential. narrative or expert review; evidence still limited PubMed 39598860 DOI 10.3390/molecules29225471
  7. 7
    In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. animal study; mechanism-focused research PubMed 33230154 DOI 10.1038/s41598-020-77175-y
  8. 8
    The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies. systematic review or meta-analysis; evidence still limited PubMed 33998900 DOI 10.1089/can.2020.0105
  9. 9
    Acidic Cannabinoids Suppress Proinflammatory Cytokine Release by Blocking Store-operated Calcium Entry. narrative or expert review; evidence still limited PubMed 35910331 DOI 10.1093/function/zqac033
  10. 10
    Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. narrative or expert review; evidence still limited PubMed 31899693 DOI 10.14309/ctg.0000000000000120
  11. 11
    Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. narrative or expert review; evidence still limited PubMed 21749363 DOI 10.1111/j.1476-5381.2011.01238.x
  12. 12
    Therapeutic potential of acidic cannabinoids: an update. narrative or expert review; evidence still limited PubMed 41545891 DOI 10.1186/s42238-026-00387-y
See all 13 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential. narrative or expert review; evidence still limited / 1 linked research note PubMed 39598860
  2. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. narrative or expert review; evidence still limited / 1 linked research note PubMed 21749363
  3. Orally administered Cannabigerol (CBG) in rats: Cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain. animal study; preclinical research / 1 linked research note PubMed 39322049
  4. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 33998900
  5. Therapeutic Effects of Non-Euphorigenic Cannabis Extracts in Osteoarthritis. animal study; preclinical research / 1 linked research note PubMed 35994012
  6. Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity. animal study; preclinical research / 1 linked research note PubMed 34577072
  7. Applications of Cannabinoids in Neuropathic Pain: An Updated Review. narrative or expert review; evidence still limited / 1 linked research note PubMed 37824417
  8. Acidic Cannabinoids Suppress Proinflammatory Cytokine Release by Blocking Store-operated Calcium Entry. narrative or expert review; evidence still limited / 1 linked research note PubMed 35910331
  9. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. narrative or expert review; evidence still limited / 1 linked research note PubMed 31899693
  10. Therapeutic potential of acidic cannabinoids: an update. narrative or expert review; evidence still limited / 1 linked research note PubMed 41545891
  11. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. animal study; mechanism-focused research / 1 linked research note PubMed 33230154
  12. Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy. animal study; mechanism-focused research / 1 linked research note PubMed 35899583
  13. Chronic Cannabigerol as an Effective Therapeutic for Cisplatin-Induced Neuropathic Pain. animal study; preclinical research / 1 linked research note PubMed 37895913